Skip to main content
Caplight Logo









Keya Medical

Keya Medical

Private
BeijingHealthcare & Life Scienceshttps://keyamedical.com

Last Round

Series D

Extension

Jul 22, 2021

Est. Valuation

$898.3M

Total Funding Raised

$251M

Company Overview

Keya Medical is a medical technology company that develops and provides artificial intelligence-based software and devices for disease diagnosis and treatment, specializing in deep learning solutions for cardiology, neurology, and pulmonology.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

medical imaging AISaMDsoftware as a medical devicedigital pathologyPACS integrationradiology AIdiagnostic imagingmedical image reconstructionclinical decision supportAI pathologyusage-based SaaShealthcare softwaremedtechdiagnostic workflowRIS integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Keya Medical Comparables

Compare Keya Medical with similar companies based on industry and business-model similarity.

Keya Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aidoc
87%
Viz.ai
83%
Qure.ai
82%

Keya Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionJul 22, 2021
Series DJan 14, 2021
Series CNov 12, 2020
Series B ExtensionAug 13, 2020
StrategicFeb 1, 2020
Series C Extension
Dec 7, 2018

Keya Medical Investors

Notable investors and investment history

Keya Medical investors
InvestorRounds
Alwin CapitalStrategic, Series B Extension, Series C
IDG CapitalStrategic, Series C
INcapital VenturesSeries D
CCIC CapitalSeries D
Taihe CapitalSeries C Extension
Tasly Holding GroupSeries C
Yueyin Medical FundSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2025

    Will be exhibiting at the RSNA 2025 conference.

  • Jul 8, 2025

    Expanding US offices to increase regional coverage.

Keya Medical Filings

Explore SEC and related filing metadata, where available.

Keya Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Keya Medical's valuation, stock price, and market status.

Is Keya Medical a public or private company?

Keya Medical is a private company.

What is the current stock price of Keya Medical?

Keya Medical is a private company, so its shares have no public market price. Caplight tracks Keya Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Keya Medical worth (valuation)?

Keya Medical's valuation is estimated at $898.3M based on funding round data.

Can I buy Keya Medical stock?

Keya Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Keya Medical's last funding round?

Keya Medical's most recent funding round was Series D Extension on July 22, 2021.

Who are the main investors in Keya Medical?

Key investors in Keya Medical include IDG Capital, Goldman Sachs Asset Management Private Equity, GGV Capital, CDH Investments.

Will Keya Medical IPO soon?

No public IPO plans have been announced for Keya Medical.

How can I track Keya Medical secondary market activity?

Caplight tracks bids, offers, and trades in Keya Medical's shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range23
Year Founded2016
Last FundingJul 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?